United States · FDA National Drug Code directory
Childrens Loratadine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51672-2073_4ef454c5-7e60-4107-e063-6394a90a6f93
- Product NDC
- 51672-2073
- Form
- SOLUTION
- Composition / generic term
- Loratadine
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20040820
- Source listing expiry
- 20271231
Source-listed ingredients
- LORATADINE — 5 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (51672-2073-4) / 60 mL in 1 BOTTLE · 51672-2073-4
- 1 BOTTLE in 1 CARTON (51672-2073-5) / 180 mL in 1 BOTTLE · 51672-2073-5
- 1 BOTTLE in 1 CARTON (51672-2073-8) / 120 mL in 1 BOTTLE · 51672-2073-8
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →